Andersen MH - Search Results

1

CCL22-based peptide vaccines induce anti-cancer immunity by modulating tumor microenvironment.

Lecoq I, Kopp KL, Chapellier M, Mantas P, Martinenaite E, Perez-Penco M, Rønn Olsen L, Zocca MB, Wakatsuki Pedersen A, Andersen MH. Lecoq I, et al. Among authors: andersen mh. Oncoimmunology. 2022 Aug 29;11(1):2115655. doi: 10.1080/2162402X.2022.2115655. eCollection 2022. Oncoimmunology. 2022. PMID: 36052217 Free PMC article.

2

Association of a functional Indoleamine 2,3-dioxygenase 2 genotype with specific immune responses.

Køllgaard T, Klausen TW, Idorn M, Holmgaard RB, Straten PT, Andersen MH. Køllgaard T, et al. Among authors: andersen mh. Oncoimmunology. 2012 Jul 1;1(4):441-447. doi: 10.4161/onci.19654. Oncoimmunology. 2012. PMID: 22754762 Free PMC article.

3

T-cell dependent immunoselection.

Andersen MH. Andersen MH. Oncoimmunology. 2012 Oct 1;1(7):1003. doi: 10.4161/onci.20927. Oncoimmunology. 2012. PMID: 23170248 Free PMC article. No abstract available.

4

CD4 responses against IDO.

Andersen MH. Andersen MH. Oncoimmunology. 2012 Oct 1;1(7):1211-1212. doi: 10.4161/onci.20780. Oncoimmunology. 2012. PMID: 23170283 Free PMC article.

5

Characterization of T-cell responses against IκBα in cancer patients.

Munir S, Frøsig TM, Hansen M, Svane IM, Andersen MH. Munir S, et al. Among authors: andersen mh. Oncoimmunology. 2012 Nov 1;1(8):1290-1296. doi: 10.4161/onci.21625. Oncoimmunology. 2012. PMID: 23243592 Free PMC article.

6

Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytes.

Donia M, Ellebaek E, Andersen MH, Straten PT, Svane IM. Donia M, et al. Among authors: andersen mh. Oncoimmunology. 2012 Nov 1;1(8):1297-1304. doi: 10.4161/onci.21659. Oncoimmunology. 2012. PMID: 23243593 Free PMC article.

7

BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transfer.

Donia M, Fagone P, Nicoletti F, Andersen RS, Høgdall E, Straten PT, Andersen MH, Svane IM. Donia M, et al. Among authors: andersen rs, andersen mh. Oncoimmunology. 2012 Dec 1;1(9):1476-1483. doi: 10.4161/onci.21940. Oncoimmunology. 2012. PMID: 23264894 Free PMC article.

8

Depletion of T lymphocytes is correlated with response to temozolomide in melanoma patients.

Iversen TZ, Brimnes MK, Nikolajsen K, Andersen RS, Hadrup SR, Andersen MH, Bastholt L, Svane IM. Iversen TZ, et al. Among authors: andersen rs, andersen mh. Oncoimmunology. 2013 Feb 1;2(2):e23288. doi: 10.4161/onci.23288. Oncoimmunology. 2013. PMID: 23525955 Free PMC article.

9

The immune checkpoint regulator PD-L1 is a specific target for naturally occurring CD4⁺ T cells.

Munir S, Andersen GH, Svane IM, Andersen MH. Munir S, et al. Among authors: andersen gh, andersen mh. Oncoimmunology. 2013 Apr 1;2(4):e23991. doi: 10.4161/onci.23991. Oncoimmunology. 2013. PMID: 23734334 Free PMC article.

10

FOXP3-specific immunity.

Andersen MH. Andersen MH. Oncoimmunology. 2013 Oct 1;2(10):e26247. doi: 10.4161/onci.26247. Epub 2013 Sep 12. Oncoimmunology. 2013. PMID: 24498544 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

386 results

Search Page

Filters